2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Peritoneal Neoplasms in 1 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
Peritoneal Neoplasms: Tumors or cancer of the PERITONEUM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zang, M | 1 |
| Zhang, B | 1 |
| Zhang, Y | 1 |
| Li, J | 1 |
| Su, L | 1 |
| Zhu, Z | 1 |
| Gu, Q | 1 |
| Liu, B | 1 |
| Yan, M | 1 |
1 other study available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Peritoneal Neoplasms
| Article | Year |
|---|---|
CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antigens, CD; Cadherins; Cell Adhesion Molecules; Cell Line | 2014 |